Looks at who completes or leaves melanoma clinical trials
Observes how often adults with melanoma finish or withdraw from clinical trials.
Key facts
- Who runs it
- Power Life Sciences Inc.
- Where
- San Francisco, United StatesSee the site
- Trial code
- Registry title
- Investigating Participation Patterns Among Stage IV Melanoma Patients
- Status
- Not yet recruiting
- People taking part
- 500 people, planned
- Started
- Nov 2024
- Expected to end
- Nov 2026
- Type of study
- Observational
- Record updated
- 23 October 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with stage IV melanoma who can understand the study and give informed consent.
- Age
- 18 years or older
- Sex
- Women and men can join.
- Disease stage
- Stage IV melanoma
Main reasons for not taking part
- Women who are pregnant or nursing
- Known psychiatric or substance abuse disorders that would interfere with cooperation with the trial
- Cannot do regular electronic reporting
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Aged ≥ 18 years old
- Diagnosis of stage IV melanoma
- Able to comprehend the investigational nature of the protocol and provide informed consent
Who cannot take part
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
- Female patients who are currently pregnant or nursing
- Inability to perform regular electronic reporting
Where in United States
- Power Life SciencesSan Francisco, United StatesContact: Michael B GillNot yet recruiting
About the trial
What the trial wants to find out
Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
Read full original descriptionShow less
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Understanding Patient Engagement Trends in Stage IV Melanoma Clinical Trials
- Plain-language title
- Looks at who completes or leaves melanoma clinical trialsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 23 October 2023